<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01198574</url>
  </required_header>
  <id_info>
    <org_study_id>SCIVA</org_study_id>
    <nct_id>NCT01198574</nct_id>
  </id_info>
  <brief_title>Sub-clinical Inflammation and Iron Supplementation</brief_title>
  <acronym>SCI&amp;Anaemia</acronym>
  <official_title>The Role of Sub-clinical Inflammation on the Iron Status of Myanmar Anaemic Adolescent Schoolgirls During Iron and Vitamin A Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Department of Medical Research, Lower Myanmar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anemia and vitamin A deficiency (VAD) are major nutritional problems in the world and also in
      Myanmar. Both nutrient deficiencies result from interaction of several causal factors, and a
      better understanding of the etiology to interpret the prevalence and to formulate appropriate
      measures to reduce these deficiencies is necessary. There is a growing concern on the role of
      sub-clinical inflammation on the nutritional status indicators during the nutritional status
      assessment. However, there is lack of information on the role of inflammation on the iron
      supplementation. The adolescent period is a window of opportunity to improve the
      preconceptional iron status of the girls and recently gained much attention. The purpose of
      the study is to understand the role of inflammation on iron and vitamin A status during iron
      and vitamin A supplementation. The findings will show the extent to which iron
      supplementation has been hampered by inflammation and to formulate the necessary measures to
      overcome the interference.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Haemoglobin Level</measure>
    <time_frame>at week 0, week 6 and week12</time_frame>
    <description>Haemoglobin level (g/L) measured by cyanmethaemoglobin method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Status of Tissue Iron Store</measure>
    <time_frame>at week 0, week 6 and week12</time_frame>
    <description>Tissue iron store was measured by serum ferritin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Status of Cellular Iron Deficiency</measure>
    <time_frame>at week 0, week 6 and week12</time_frame>
    <description>Cellular Iron deficiency status is also measured by serum transferrin receptor</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">402</enrollment>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>Iron group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin A group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin A group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Iron and Vitamin A group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iron and Vitamin A group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo group with folic acid</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iron group</intervention_name>
    <description>Ferrous fumarate, 60 mg, weekly dose</description>
    <arm_group_label>Iron group</arm_group_label>
    <other_name>Iron supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin A group</intervention_name>
    <description>Retinol, weekly dose, 15,000 IU</description>
    <arm_group_label>Vitamin A group</arm_group_label>
    <other_name>Vitamin A supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Iron and vitamin A group</intervention_name>
    <description>Ferrous fumarate, Retinol combination group, weekly dose</description>
    <arm_group_label>Iron and Vitamin A group</arm_group_label>
    <other_name>Iron and Vitamin A supplement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo group</intervention_name>
    <description>folic acid only as placebo group</description>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Placebo group, folic acid only</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adolescent girls (age 12-19 years)

          -  already experienced menarche

          -  anemic girls (Hb&lt;120 g/L)

          -  no known illness (apparently healthy)

          -  free from haemoglobinopathy

          -  No regular consumption of iron and vitamin A supplement during the last 3 months

        Exclusion Criteria:

          -  subjects with chronic illness

          -  subjects with severe anaemia

          -  who do not give the consents
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Min Kyaw Htet, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>(1) South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition, University of Indonesia, (2) Ministry of Health, Myanmar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nyaung Done Township</name>
      <address>
        <city>Pathein</city>
        <state>Irrawaddy Division</state>
        <country>Myanmar</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Myanmar</country>
  </location_countries>
  <link>
    <url>http://www.seameo-recfon.org/</url>
    <description>South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition, University of Indonesia</description>
  </link>
  <reference>
    <citation>Thurnham DI, McCabe LD, Haldar S, Wieringa FT, Northrop-Clewes CA, McCabe GP. Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. Am J Clin Nutr. 2010 Sep;92(3):546-55. doi: 10.3945/ajcn.2010.29284. Epub 2010 Jul 7.</citation>
    <PMID>20610634</PMID>
  </reference>
  <reference>
    <citation>Mburu AS, Thurnham DI, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV+ Kenyan adults. J Nutr. 2008 Mar;138(3):613-9.</citation>
    <PMID>18287375</PMID>
  </reference>
  <reference>
    <citation>Thurnham DI, Mburu AS, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. Using plasma acute-phase protein concentrations to interpret nutritional biomarkers in apparently healthy HIV-1-seropositive Kenyan adults. Br J Nutr. 2008 Jul;100(1):174-82. doi: 10.1017/S0007114507883012. Epub 2008 Jan 4.</citation>
    <PMID>18177514</PMID>
  </reference>
  <reference>
    <citation>Thurnham DI, Mburu AS, Mwaniki DL, De Wagt A. Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc. 2005 Nov;64(4):502-9. Review.</citation>
    <PMID>16313694</PMID>
  </reference>
  <reference>
    <citation>Thurnham DI. Vitamin A, iron, and haemopoiesis. Lancet. 1993 Nov 27;342(8883):1312-3.</citation>
    <PMID>7901629</PMID>
  </reference>
  <reference>
    <citation>Angeles-Agdeppa I, Schultink W, Sastroamidjojo S, Gross R, Karyadi D. Weekly micronutrient supplementation to build iron stores in female Indonesian adolescents. Am J Clin Nutr. 1997 Jul;66(1):177-83.</citation>
    <PMID>9209187</PMID>
  </reference>
  <reference>
    <citation>Tee ES, Kandiah M, Awin N, Chong SM, Satgunasingam N, Kamarudin L, Milani S, Dugdale AE, Viteri FE. School-administered weekly iron-folate supplements improve hemoglobin and ferritin concentrations in Malaysian adolescent girls. Am J Clin Nutr. 1999 Jun;69(6):1249-56.</citation>
    <PMID>10357747</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2010</study_first_submitted>
  <study_first_submitted_qc>September 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2010</study_first_posted>
  <results_first_submitted>December 31, 2011</results_first_submitted>
  <results_first_submitted_qc>April 17, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 16, 2012</results_first_posted>
  <last_update_submitted>May 15, 2012</last_update_submitted>
  <last_update_submitted_qc>May 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Min Kyaw Htet</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>anemia</keyword>
  <keyword>iron supplementation</keyword>
  <keyword>sub-clinical inflammation</keyword>
  <keyword>adolescents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin A</mesh_term>
    <mesh_term>Iron</mesh_term>
    <mesh_term>Ferrous fumarate</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
    <mesh_term>Retinol palmitate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Screening for the study subjects was conducted in July, 2010 among the adolescent schoolgirls in Nyaung Done Township, Irrawaddy Division. It included assessment of Hb status using the Coulter Counter. Information on the general characteristics and menarche status of the girls are obtained.</recruitment_details>
      <pre_assignment_details>Deworming with 400 mg Albendazole was done one week before the baseline data collection.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Iron Group</title>
          <description>Iron group received 60 mg of elemental iron, 2.5 mg folic acid + Placebo Vitamin A weekly</description>
        </group>
        <group group_id="P2">
          <title>Vitamin A Group</title>
          <description>Vitamin A group received 15,000 IU Vitamin A + Placebo iron containing 2.5 mg folic acid weekly</description>
        </group>
        <group group_id="P3">
          <title>Iron and Vitamin A Group</title>
          <description>Iron and Vitamin A group received 60 mg elemental iron, 2.5 mg folic acid + 15,000 IU Vitamin A weekly</description>
        </group>
        <group group_id="P4">
          <title>Placebo Group</title>
          <description>Placebo group received 2.5 mg folic acid weekly</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="98"/>
                <participants group_id="P2" count="102"/>
                <participants group_id="P3" count="100"/>
                <participants group_id="P4" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="94"/>
                <participants group_id="P2" count="101"/>
                <participants group_id="P3" count="99"/>
                <participants group_id="P4" count="98"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Resigned from schools</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Iron Group</title>
          <description>Iron group received 60 mg elemental iron, 2.5 mg folic acid with vitamin A placebo weekly</description>
        </group>
        <group group_id="B2">
          <title>Vitamin A Group</title>
          <description>Vitamin A group received 15,000 IU Vitamin A + Iron placebo with 2.5 mg folic acid weekly</description>
        </group>
        <group group_id="B3">
          <title>Iron and Vitamin A Group</title>
          <description>Iron and Vitamin A group received 60 mg elemental iron, 2.5 mg folic acid +15,000 IU Vitamin A weekly</description>
        </group>
        <group group_id="B4">
          <title>Placebo Group</title>
          <description>Placebo group received iron placebo containing 2.5 mg folic acid weekly</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="98"/>
            <count group_id="B2" value="102"/>
            <count group_id="B3" value="100"/>
            <count group_id="B4" value="102"/>
            <count group_id="B5" value="402"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="102"/>
                    <measurement group_id="B5" value="402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15.9" spread="1.2"/>
                    <measurement group_id="B2" value="16.1" spread="1.2"/>
                    <measurement group_id="B3" value="16.1" spread="1.2"/>
                    <measurement group_id="B4" value="15.8" spread="1.1"/>
                    <measurement group_id="B5" value="16.0" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="102"/>
                    <measurement group_id="B5" value="402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Myanmar</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="98"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="102"/>
                    <measurement group_id="B5" value="402"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Haemoglobin Level</title>
        <description>Haemoglobin level (g/L) measured by cyanmethaemoglobin method</description>
        <time_frame>at week 0, week 6 and week12</time_frame>
        <population>Per Protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Iron Group</title>
            <description>60 mg Elemental iron with 2.5 mg folic acid + Vitamin A placebo</description>
          </group>
          <group group_id="O2">
            <title>Vitamin A Group</title>
            <description>15,000 IU vitamin A + Iron Placebo containing 2.5 mg folic acid</description>
          </group>
          <group group_id="O3">
            <title>Iron and Vitamin A Group</title>
            <description>60 mg Elemental iron with 2.5 mg folic acid + Vitamin A 15,000 IU</description>
          </group>
          <group group_id="O4">
            <title>Placebo Group</title>
            <description>2.5 mg folic acid + Vitamin A placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Haemoglobin Level</title>
          <description>Haemoglobin level (g/L) measured by cyanmethaemoglobin method</description>
          <population>Per Protocol</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="94"/>
                <count group_id="O2" value="101"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hb week 0 (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.3" spread="11.2"/>
                    <measurement group_id="O2" value="89.2" spread="11.5"/>
                    <measurement group_id="O3" value="88.4" spread="12.1"/>
                    <measurement group_id="O4" value="89.6" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hb week 6 (Midline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.1" spread="10.6"/>
                    <measurement group_id="O2" value="98.7" spread="9.6"/>
                    <measurement group_id="O3" value="99.2" spread="10.0"/>
                    <measurement group_id="O4" value="98.3" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hb week 12 (Endline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110.8" spread="9.8"/>
                    <measurement group_id="O2" value="109.0" spread="9.1"/>
                    <measurement group_id="O3" value="111.4" spread="9.0"/>
                    <measurement group_id="O4" value="109.7" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Null Hypothesis
Haemoglobin level was not influenced by sub-clinical inflammation during iron supplementation in the anaemic adolescent school girls
Vitamin A does not improve the haemoglobin level of the anaemic schoolgirls during iron supplementation in the presence of inflammation.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>GLM for repeated measures</method>
            <method_desc>The Hb concentration at Week 0, Week 6 and Week 12 are analyzed using GLM repeated measures.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Status of Tissue Iron Store</title>
        <description>Tissue iron store was measured by serum ferritin</description>
        <time_frame>at week 0, week 6 and week12</time_frame>
        <population>Per Protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Iron Group</title>
            <description>60 mg Elemental iron with 2.5 mg folic acid + Vitamin A placebo</description>
          </group>
          <group group_id="O2">
            <title>Vitamin A Group</title>
            <description>15,000 IU vitamin A + Iron Placebo containing 2.5 mg folic acid</description>
          </group>
          <group group_id="O3">
            <title>Iron and Vitamin A Group</title>
            <description>60 mg Elemental iron with 2.5 mg folic acid + Vitamin A 15,000 IU</description>
          </group>
          <group group_id="O4">
            <title>Placebo Group</title>
            <description>2.5 mg folic acid + Vitamin A placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Status of Tissue Iron Store</title>
          <description>Tissue iron store was measured by serum ferritin</description>
          <population>Per Protocol analysis</population>
          <units>Âµg/L</units>
          <param>Geometric Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="94"/>
                <count group_id="O2" value="101"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>serum ferritin (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.1" spread="2.5"/>
                    <measurement group_id="O2" value="34.4" spread="2.6"/>
                    <measurement group_id="O3" value="25.9" spread="3.1"/>
                    <measurement group_id="O4" value="31.1" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>serum ferritin (Midline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" spread="1.9"/>
                    <measurement group_id="O2" value="32.1" spread="2.3"/>
                    <measurement group_id="O3" value="32.3" spread="2.1"/>
                    <measurement group_id="O4" value="26.5" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>serum ferritin (Endline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.6" spread="2.1"/>
                    <measurement group_id="O2" value="35.0" spread="2.5"/>
                    <measurement group_id="O3" value="35.4" spread="2.4"/>
                    <measurement group_id="O4" value="28.2" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis
Iron status indicator (serum ferritin) was not influenced by sub-clinical inflammation during iron supplementation in the anaemic adolescent school girls
Vitamin A does not improve the iron status indicator (serum ferritin) concentration of the anaemic schoolgirls during iron supplementation in the presence of inflammation.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>GLM for repeated measures ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Status of Cellular Iron Deficiency</title>
        <description>Cellular Iron deficiency status is also measured by serum transferrin receptor</description>
        <time_frame>at week 0, week 6 and week12</time_frame>
        <population>Per Protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Iron Group</title>
            <description>60 mg Elemental iron with 2.5 mg folic acid + Vitamin A placebo</description>
          </group>
          <group group_id="O2">
            <title>Vitamin A Group</title>
            <description>15,000 IU vitamin A + Iron Placebo containing 2.5 mg folic acid</description>
          </group>
          <group group_id="O3">
            <title>Iron and Vitamin A Group</title>
            <description>60 mg Elemental iron with 2.5 mg folic acid + Vitamin A 15,000 IU</description>
          </group>
          <group group_id="O4">
            <title>Placebo Group</title>
            <description>2.5 mg folic acid + Vitamin A placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Status of Cellular Iron Deficiency</title>
          <description>Cellular Iron deficiency status is also measured by serum transferrin receptor</description>
          <population>Per Protocol analysis</population>
          <units>mg/L</units>
          <param>Geometric Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="94"/>
                <count group_id="O2" value="101"/>
                <count group_id="O3" value="98"/>
                <count group_id="O4" value="98"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>serum transferrin receptor (Baseline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.09" spread="1.52"/>
                    <measurement group_id="O2" value="6.56" spread="1.42"/>
                    <measurement group_id="O3" value="7.16" spread="1.59"/>
                    <measurement group_id="O4" value="6.74" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>serum transferrin receptor (Midline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.69" spread="1.51"/>
                    <measurement group_id="O2" value="6.39" spread="1.41"/>
                    <measurement group_id="O3" value="6.73" spread="1.53"/>
                    <measurement group_id="O4" value="6.59" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>serum transferrin receptor (Endline)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.44" spread="1.55"/>
                    <measurement group_id="O2" value="6.27" spread="1.44"/>
                    <measurement group_id="O3" value="6.24" spread="1.43"/>
                    <measurement group_id="O4" value="6.61" spread="1.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Null Hypothesis
iron status indicator (sTfR) was not influenced by sub-clinical inflammation during iron supplementation in the anaemic adolescent school girls
Vitamin A does not improve iron status indicator (sTfR) of the anaemic schoolgirls during iron supplementation in the presence of inflammation.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>GLM for repeated measures ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse effect of supplementation were collected weekly throughout the 12 weeks of intervention.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Iron Group</title>
          <description>Iron group received 60 mg elemental iron, 2.5 mg folic acid with vitamin A placebo weekly</description>
        </group>
        <group group_id="E2">
          <title>Vitamin A Group</title>
          <description>Vitamin A group received 15,000 IU Vitamin A + Iron placebo with 2.5 mg folic acid weekly</description>
        </group>
        <group group_id="E3">
          <title>Iron and Vitamin A Group</title>
          <description>Iron and Vitamin A group received 60 mg elemental iron, 2.5 mg folic acid +15,000 IU Vitamin A weekly</description>
        </group>
        <group group_id="E4">
          <title>Placebo Group</title>
          <description>Placebo group received iron placebo containing 2.5 mg folic acid weekly</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="102"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="102"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar</name_or_title>
      <organization>South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition</organization>
      <phone>+62-857-27262672</phone>
      <email>kyawhtet@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

